Top compounds associated with response to FHL1


Feature Type Standardized
Nominal ANOVA
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Erlotinib CCLE pan-cancer AAC -0.15 0.002
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.1 0.003
mRNA AT-406 CTRPv2 pan-cancer AAC 0.15 0.003
mRNA PD-0325901 CCLE pan-cancer AAC -0.14 0.003
mRNA clofarabine CTRPv2 pan-cancer AAC -0.088 0.003
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.004
mRNA BX-795 GDSC1000 pan-cancer AAC 0.11 0.004
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.004
Download CSV